semaglutide addictive behavior Do New Obesity and Diabetes Drugs Also Curb Drinking, Gambling, and Other Addictions? | BU Today Semaglutide in Substance Use Disorders:

Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with adverse outcomes such as cirrhosis, malignancy, transplantation, and mortality

Learn whether tirzepatide affects vein health, how weight loss may influence venous conditions, and when to seek medical advice for leg symptoms whilst taking this medication.

Heart palpitations can occur during GLP-1 therapy, but understanding the mechanisms and proper monitoring helps minimize risk

GLP-1s are proving their value well beyond the scale, with benefits ranging from improved glycemic control and reduced cardiovascular risk to better mobility and quality of life

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with diabetes took the blockbuster drugs, including Wegovy, Ozempic and Zepbound.